Overview and Scope
Anaphylaxis treatment refers to the treatment of life-threatening allergic reactions to foods, insect stings, medications, and latex in which immediate administration of epinephrine is given to reverse the allergic reaction and stabilize the patient’s condition. Rapid medical treatment and comprehensive supportive care are required to effectively manage potentially life-threatening symptoms of anaphylaxis.
Sizing and Forecast
The anaphylaxis treatment market size has grown strongly in recent years. It will grow from $5.73 billion in 2023 to $6.15 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing incidence of allergic reactions, wider recognition of anaphylaxis, increased availability of epinephrine auto-injectors, public awareness and education, healthcare professional training.
The anaphylaxis treatment market size is expected to see strong growth in the next few years. It will grow to $7.97 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to innovation in biologic therapies, customized treatment approaches, global efforts on food safety, patient empowerment and advocacy, enhanced emergency medical services. Major trends in the forecast period include auto-injectors innovation, telemedicine for anaphylaxis management, improved allergen immunotherapy, biometric wearables for allergen detection, collaborations in allergy research.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report
Segmentation & Regional Insights
The anaphylaxis treatment market covered in this report is segmented –
1) By Treatment: Epinephrine, Antihistamines, Steroids, Beta-antagonists, Other Treatments
2) By Product: Tablets, Capsules, Other Products
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications
North America was the largest region in the anaphylaxis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anaphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp
Major Driver Impacting Market Growth
The rise in the prevalence of food allergies is expected to propel the growth of the anaphylaxis treatment market going forward. Food allergy refers to an immune reaction to proteins in food. Anaphylaxis treatment helps to prevent the progression of life-threatening allergic symptoms involving the skin, mucosal surface, respiratory compromise, hypotension, and end-organ dysfunction. For instance, in January 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2021, 31.8% of adults aged 18 and older reported having eczema, a seasonal allergy, or a food allergy. One-fourth (25.7%) of adults had a seasonal allergy, 6.2% had a food allergy, and 7.3% of individuals had eczema. Therefore, the rise in the prevalence of food allergies is driving the growth of the anaphylaxis treatment market.
Key Industry Players
Major companies operating in the anaphylaxis treatment market report are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Abbott Laboratories, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Bausch Health Companies, Sun Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abelló A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., MannKind Corporation, Meridian Medical Technologies LLC, Aquestive Therapeutics Inc., Sandoz Inc., Bioprojet SCR, Adamis Pharmaceutical Corporation, Impax Laboratories LLC.
The anaphylaxis treatment market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The global Immunotherapy market is all set to gain substantial demand opportunities from various end-use industries, according to a new report from Factor.
Detailed information on consumptions and demand ratio of diverse products/services linked to the growth dynamics of the Pediatric Neuroblastoma Treatment market is covered in this report.
This aside, the report presents reliable data on revenues and volumes of all key geographical regions during the forecast period 2020 to 2026.The report on the global Pediatric Neuroblastoma Treatment market works as a helpful guide that provides dependable data on various aspects such as challenges and opportunities in this market.
In addition to this, readers of this report will get an in-depth analysis of diverse trends together with technological and product developments in the global Pediatric Neuroblastoma Treatment market.
The analysts have used diverse business intelligence tools to present trustworthy data on diverse aspects such as statistics and facts on important aspects of the global Pediatric Neuroblastoma Treatment market.The approval of orphan drugs such as CLR 131 Phospholipid Drug Conjugate (PDC), developed by Cellectar Biosciences shall leverage the market during the forecast period (2020-2026), at a staggering CAGR of 9.2%.The report covers an analysis of the competitive landscape of the global Pediatric Neuroblastoma Treatment market together with a detailed study of the most important players working in this market.
The list of key players studied in this report includes:United Therapeutics CorporationAPEIRON Biologics AGBaxterBayer AGIn addition to this, the report sheds light on diverse strategies executed by market players to gain the leading position in the market for Pediatric Neuroblastoma Treatment.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.
Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.
Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.
Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.
A spice is a dried seed, fruit, root, bark, or vegetable substance primarily used for flavoring, coloring or preserving food.
Because they tend to have strong flavors and are used in small quantities, spices tend to add few calories to food.
Included are tropical aromatics (pepper, cinnamon, cloves, etc.
and dehydrated vegetables (onions, garlic, etc.).
Blends such as curry, chili powders, poultry seasoning, etc.
are part of the spice shelf, too.Get Sample Copy of this Report @ https://dataintelo.com/request-sample/?reportId=599The FDA defines spices similarly, except that they do not include the dehydrated vegetables in the label definition of spice.
Index Markets Research analytical assessment on Mattress Toppers Market classification techniques, upgrade investments, comprehend provider and market difficulties, and execute sourcing best practices. The research report covers qualitative and quantative market data outlook on product Scope,issues, influencing factors and key market trends and drivers that are changing the dynamics of Mattress Toppers market. The key manufacturers are listed here : Serta, Sealy, Tempur-Pedic, Simmons, Select Comfort Corporation, Sleep Innovations, Dreamfoam Bedding, McRoskey, Organic Mattresses, Inc, Memory Foam Solutions, Airweave, Milliard Bedding, Healthcare Co., Ltd., Devon Duvets, Vita Talalay.
Request for Sample Report @ https://www.indexmarketsresearch.com/report/global-and-europe-mattress-toppers-market/1570/#requestforsample
The Mattress Toppers Market research report of 103 pages with detailed analysis, forecast and strategies about the market current scenario as well as its future projections on a global and regional level. It encourage strongly to provide major insights into the market’s growth throughout the above-mentioned forecast period in terms of volume (in kilo tons) and revenue (in US$). The SWOT Analysis of market study companies Basic Information, Manufacturing Base, Sales Area and Its Competitors, in-depth business overview, geographic footprint and contact information. To determine the market potential for Mattress Toppers the worldwide situation, the investigation dives into the competitive landscape and development landscape exhibited by the key geographic regions.
Apart from this the analysts study on the Mattress Toppers market have also conducted upstream raw materials and equipment and downstream demand analysis request examination to gather and present a thorough investigation. The report investigates the patterns that will impact the growth market revenue, top strategies, innovations, collaborations, and other developments are mentioned in detail in the report. Other parameters crucial in determining trends in the market such as consumption demand and supply figures, cost of production, gross profit margins, and selling price of product and services is additionally included inside the ambit of the report.
Geographically, this report is segmented into several key Regions such as North America, China, Europe, Southeast Asia, Japan & India.
Mattress Toppers Market Analysis by Product Type Segmentation : Memory Foam Mattress Topper, Latex Mattress Topper, Feather Mattress Topper, Wool Mattress Topper
Mattress Toppers Market Analysis by Application Segmentation : Residential, Hotels, Others
Key Highlight Points of this report :
1) Detailed Overview of influential factors to market helps deliver clients and businesses making strategies.
2) Creative mapping the present key trends and latest technological advancements.
3) Analysis of trending factors influencing the Market shares in next few years.
4) Strategic recommendations for the new entrants/to Grow your business.
5) Application/end-user category or Product Type may see incremental growth prospects.
Inquiry for Buying Report @ https://www.indexmarketsresearch.com/report/global-and-europe-mattress-toppers-market/1570/#inquiry
In conclusion, The Mattress Toppers statistical surveying study gives historical and projected market data in tabular format share along with the growth rate, revenue figures and gross profit margin which makes straightforward towards product/service differences, market concentration rate and product distribution for past 5 years. The report offers a quantifiable and verifiable method made towards investigation of market concentration, new entrants and the innovative patterns in future.
About Us
Index Markets Research conduct market research and publish reports. You can find more than 35,000 research reports in our web store, which covers global industry and the regional markets. All the worldwide marketing data you need is at your fingertips.
Contact Us
Mark Irwin
Sales Manager
Email Id: [email protected]
Phone: +1 202 888 3519
Web: https://www.indexmarketsresearch.com/
